Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 May;4(2):92-6.
doi: 10.1159/000339446. Epub 2012 May 31.

Childhood stiff-person syndrome improved with rituximab

R Fekete  1 , J Jankovic
Affiliations
Case Reports

Childhood stiff-person syndrome improved with rituximab

R Fekete et al. Case Rep Neurol. 2012 May.

Abstract

Introduction: Stiff-person syndrome (SPS) is manifested by fluctuating rigidity of axial musculature with painful episodic spasms due to simultaneous co-contraction of agonist and antagonist muscles. We present a case report and video illustrating response to treatment with rituximab.

Materials and methods: Case description and video are provided. A literature search for other reports of treatment with rituximab was performed.

Results: Nine cases in addition to our case were described. Substantial clinical benefit was reported in 7/9 (78%) cases. Four out of 9 (44%) cases displayed persistent anti-glutamic acid decarboxylase (GAD) antibody positivity.

Conclusion: Rituximab is an important treatment strategy in SPS. The persistence of anti-GAD antibody positivity even with clinical remission remains to be elucidated.

Keywords: Myoclonus; Rituximab; Stiff-person syndrome.

PubMed Disclaimer

References

    1. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm (‘stiff-man syndrome’): report of a case and some observations in 13 other cases. Mayo Clin Proc. 1956;31:421–427. - PubMed
    1. Alexopoulos H, Dalakas MC. A critical update on the immunopathogenesis of stiff person syndrome. Eur J Clin Invest. 2010;40:1018–1025. - PubMed
    1. Geis C, Weishaupt A, Hallermann S, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain. 2010;133:3166–3180. - PubMed
    1. Dalakas MC, Fujii M, Li M, Lufti B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff person syndrome. N Engl J Med. 2001;345:1870–1876. - PubMed
    1. Lobo M, Araújo MLB, Tomaz CAB, Allam N. Stiff-person syndrome treated with rituximab. BMJ Case Reports, Epub. 2010 - PMC - PubMed

Publication types